Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CASI Pharmaceuticals Inc CASI

Healthcare Biotechnology
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its... see more

Recent & Breaking News (NDAQ:CASI)

CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors

PR Newswire September 23, 2014

Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs

Business Wire September 18, 2014

Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs

PR Newswire September 18, 2014

CASI Pharmaceuticals Reports Second Quarter 2014 Financial Results

PR Newswire August 14, 2014

CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China

PR Newswire July 21, 2014

CASI Pharmaceuticals Receives U.S. Orphan Drug Designation For The Use Of ENMD-2076 To Treat Hepatocellular Carcinoma

PR Newswire July 7, 2014

EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals

PR Newswire June 13, 2014

EntreMed appoints Franklin C. Salisbury, Jr., President of NFCR, to Board of Directors

PR Newswire June 3, 2014

EntreMed Announces Poster Presentations At ASCO On ENMD-2076

PR Newswire May 19, 2014

EntreMed Reports First Quarter 2014 Financial Results

PR Newswire May 15, 2014

EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results

PR Newswire March 21, 2014

EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA

PR Newswire January 13, 2014

EntreMed Reports Third Quarter 2013 Financial Results

PR Newswire November 14, 2013

Data Presented For ENMD-2076 In Xenograft Models Of Human Hepatocellular Carcinoma

PR Newswire October 22, 2013

Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer

PR Newswire October 21, 2013

EntreMed Reports Second Quarter 2013 Financial Results

PR Newswire August 14, 2013

EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials

PR Newswire July 29, 2013

EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA To Expand Clinical Trial For Advanced/Metastatic Sarcoma

PR Newswire June 27, 2013

EntreMed Reports First Quarter 2013 Financial Results

PR Newswire May 15, 2013

Patent Issued In China For EntreMed's Lead Drug Candidate ENMD-2076

PR Newswire May 6, 2013